EX-23.1 4 crvs-20201231xex23d1.htm EX-23.1

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-237040), and Form S-8 (No. 333-223622, No. 333-216590, No. 333-210456, No. 333-231331 and No. 333-237933) of Corvus Pharmaceuticals. Inc. of our report dated March 25, 2021 relating to the financial statements, which appear in this Form 10-K.

/s/ PricewaterhouseCoopers LLP

San Jose, California

March 25, 2021